|
|
|
Insider
Information: |
Tang Capital Partners Lp |
Relationship: |
10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
123,746 |
|
Indirect Shares
|
35,438,120 |
|
|
Direct
Value |
$27,818 |
|
|
Indirect Value
|
$75,698,131 |
|
|
Total
Shares |
35,561,866 |
|
|
Total
Value |
$75,725,949 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
11
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-4.3%
|
-74.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-03-09 |
4 |
B |
$1.39 |
$411,884 |
I/I |
296,362 |
6,336,498 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-05 |
4 |
B |
$4.50 |
$425,819 |
I/I |
94,700 |
1,704,561 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-03-06 |
4 |
B |
$1.39 |
$437,307 |
I/I |
309,300 |
6,040,136 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-06-11 |
4 |
OE |
$1.03 |
$440,217 |
I/I |
426,154 |
2,144,896 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-05 |
4 |
B |
$11.78 |
$459,330 |
I/I |
39,000 |
2,249,067 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-11-07 |
4 |
B |
$0.83 |
$464,296 |
I/I |
560,000 |
3,520,852 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-11-13 |
4 |
B |
$1.25 |
$499,920 |
I/I |
400,000 |
2,778,926 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-19 |
4 |
B |
$13.25 |
$499,936 |
I/I |
37,731 |
2,300,798 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2010-01-05 |
4 |
S |
$11.48 |
$522,263 |
I/I |
(45,500) |
2,920,352 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2017-02-23 |
4 |
B |
$4.34 |
$582,079 |
I/I |
134,200 |
559,900 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2010-01-14 |
4 |
S |
$10.73 |
$589,181 |
I/I |
(54,900) |
2,715,852 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-04 |
4 |
B |
$10.76 |
$601,021 |
I/I |
55,850 |
2,210,067 |
1.5 |
- |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-05-30 |
4 |
B |
$1.00 |
$608,655 |
I/I |
588,768 |
3,240,836 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-25 |
4 |
B |
$1.04 |
$622,680 |
I/I |
600,000 |
5,619,058 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2008-09-30 |
4 |
B |
$0.97 |
$627,900 |
I/I |
650,000 |
5,355,693 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2008-10-10 |
4 |
B |
$0.74 |
$647,019 |
I/I |
870,000 |
6,225,693 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2009-10-15 |
4 |
S |
$11.80 |
$683,782 |
I/I |
(57,928) |
3,065,852 |
0 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2008-04-22 |
4 |
B |
$1.00 |
$685,604 |
I/I |
685,612 |
4,689,997 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-21 |
4 |
B |
$3.57 |
$714,000 |
I/I |
200,000 |
1,003,355 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-11-18 |
4 |
B |
$1.00 |
$736,838 |
I/I |
685,000 |
3,463,926 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2015-06-02 |
4 |
B |
$23.84 |
$772,294 |
I/I |
32,395 |
4,746,318 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2010-01-13 |
4 |
S |
$10.54 |
$912,065 |
I/I |
(86,500) |
2,770,752 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-19 |
4 |
B |
$0.98 |
$1,058,478 |
I/I |
1,080,852 |
4,839,058 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-17 |
4 |
B |
$1.65 |
$1,096,652 |
I/I |
665,000 |
5,506,196 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2010-01-04 |
4 |
S |
$11.65 |
$1,165,320 |
I/I |
(100,000) |
2,965,852 |
0 |
- |
|
176 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|